Neurosurgeons' perspectives on psychosurgery and neuroenhancement: a qualitative study at one center

Clinical article

Restricted access

Object

Advances in the neurosciences are stirring debate regarding the ethical issues surrounding novel neurosurgical interventions. The application of deep brain stimulation (DBS) for treating refractory psychiatric disease, for instance, has introduced the prospect of altering disorders of mind and behavior and the potential for neuroenhancement. The attitudes of current and future providers of this technology and their position regarding its possible future applications are unknown. The authors sought to gauge the opinions of neurosurgical staff and trainees toward various uses of neuromodulation technology including psychosurgery and neuroenhancement.

Methods

The authors conducted a qualitative study involving in-depth interviews with 47 neurosurgery staff, trainees, and other neuroclinicians at a quaternary care center.

Results

Several general themes emerged from the interviews. These included universal support for psychosurgery given adequate informed consent and rigorous scientific methodology, as well as a relative consensus regarding the priority given to patient autonomy and the preservation of personal identity. Participants' attitudes toward the future use of DBS and other means of neuromodulation for cognitive enhancement and personality alteration revealed less agreement, although most participants felt that alteration of nonpathological traits is objectionable.

Conclusions

There is support in the neurosurgical community for the surgical management of refractory psychiatric disease. The use of neuromodulation for the alteration of nonpathological traits is morally and ethically dubious when it is out of sync with the values of society at large. Both DBS and neuromodulation will have far-reaching and profound public health implications.

Abbreviations used in this paper: DBS = deep brain stimulation; GKS = Gamma Knife surgery; OCD = obsessive-compulsive disorder; PTSD = posttraumatic stress disorder.

Article Information

Address correspondence to: Mark Bernstein, M.D., Division of Neurosurgery, Toronto Western Hospital, West Wing, Room 4W451, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8. email: mark.bernstein@uhn.on.ca.

Please include this information when citing this paper: published online June 4, 2010; DOI: 10.3171/2010.5.JNS091896.

© AANS, except where prohibited by US copyright law.

Headings

References

1

Abi-Rached JM: The implications of the new brain sciences. The ‘Decade of the Brain' is over but its effects are now becoming visible as neuropolitics and neuroethics, and in the emergence of neuroeconomies. EMBO Rep 9:115811622008

2

Anonymous: Editorial. Neuroethics needed. Nature 441:9072006

3

Awan NRLozano AHamani C: Deep brain stimulation: current and future perspectives. Neurosurg Focus 27:1E22009

4

Cheshire WP: Neuroscience, nuance, and neuroethics. Ethics Med 22:71732006

5

DeGrazia D: Enhancement technologies and human identity. J Med Philos 30:2612832005

6

Feldman RPAlterman RLGoodrich JT: Contemporary psychosurgery and a look to the future. J Neurosurg 95:9449562001

7

Friehs GMPark MCGoldman MAZerris VANorén GSampath P: Stereotactic radiosurgery for functional disorders. Neurosurg Focus 23:6E32007

8

Fuchs T: Ethical issues in neuroscience. Curr Opin Psychiatry 19:6006072006

9

Glannon W: Deep-brain stimulation for depression. HEC Forum 20:3253352008

10

Glannon W: Neuroethics. Bioethics 20:37522006

11

Hamani CMayberg HSnyder BGiacobbe PKennedy SLozano AM: Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting. Clinical article. J Neurosurg 111:120912152009

12

Hamani CMcAndrews MPCohn MOh MZumsteg DShapiro CM: Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol 63:1191232008

13

Illes J: Neuroethics in a new era of neuroimaging. AJNR Am J Neuroradiol 24:173917412003

14

Illes JLombera SRosenberg JArnow B: In the mind's eye: provider and patient attitudes on functional brain imaging. J Psychiatr Res 43:1071142008

15

Kaplan HISadock BJFreedman AM: Modern Synopsis of Comprehensive Textbook of Psychiatry ed 3BaltimoreWilliams & Wilkins1981. 822825

16

Larson PS: Deep brain stimulation for psychiatric disorders. Neurotherapeutics 5:50582008

17

Leshner AI: It's time to go public with neuroethics. Am J Bioeth 5:122005

18

Lipsman NZener RBernstein M: Personal identity, enhancement and neurosurgery: a qualitative study in applied neuroethics. Bioethics 23:3753832009

19

Pitman RKSanders KMZusman RMHealy ARCheema FLasko NB: Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51:1891922002

20

President's Council on Bioethics: Beyond Therapy: Biotechnology and the Pursuit of Human Improvement Washington, DCDana Press2003. 214234

21

Reichlin M: The challenges of neuroethics. Funct Neurol 22:2352422007

22

Roskies A: Neuroethics for the new millenium. Neuron 35:21232002

23

Secko DMBurgess MO'Doherty K: Perspectives on engaging the public in the ethics of emerging biotechnologies: from salmon to biobanks to neuroethics. Account Res 15:2833022008

24

Sententia W: Neuroethical considerations: cognitive liberty and converging technologies for improving human cognition. Ann N Y Acad Sci 1013:2212282004

25

Strauss ALCorbin JM: Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory ed 2Thousand Oaks, CASage Publications1998. 101137

26

Swayze VW II: Frontal leukotomy and related psychosurgical procedures in the era before antipsychotics (1935–1954): a historical overview. Am J Psychiatry 152:5055151995

27

Timpane J: Models for the neuroethical debate in the community. Cerebrum 6:1001072004

28

Toyota Canada Inc: Real-time control of wheelchairs with brain waves (http://media.toyota.ca/pr/tci/en/real-time-control-of-wheelchairs-950391.aspx

29

Vaiva GDucrocq FJezequel KAverland BLestavel PBrunet A: Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 54:9479492003

30

Warnick JE: Propranolol and its potential inhibition of positive post-traumatic growth. Am J Bioeth 7:37382007

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 31 31 31
Full Text Views 187 187 43
PDF Downloads 105 105 42
EPUB Downloads 0 0 0

PubMed

Google Scholar